- Home
- AGEN vs QSG Comparison
AGEN vs QSG Comparison
Compare AGEN & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- QSG
- Stock Information
- Founded
- AGEN 1994
- QSG 2019
- Country
- AGEN United States
- QSG China
- Employees
- AGEN N/A
- QSG N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- QSG Other Consumer Services
- Sector
- AGEN Health Care
- QSG Real Estate
- Exchange
- AGEN Nasdaq
- QSG Nasdaq
- Market Cap
- AGEN 96.2M
- QSG 99.2M
- IPO Year
- AGEN 2000
- QSG 2023
- Fundamental
- Price
- AGEN $2.83
- QSG $1.94
- Analyst Decision
- AGEN Buy
- QSG
- Analyst Count
- AGEN 3
- QSG 0
- Target Price
- AGEN $10.50
- QSG N/A
- AVG Volume (30 Days)
- AGEN 566.5K
- QSG 116.8K
- Earning Date
- AGEN 11-12-2024
- QSG 11-27-2024
- Dividend Yield
- AGEN N/A
- QSG N/A
- EPS Growth
- AGEN N/A
- QSG 662.58
- EPS
- AGEN N/A
- QSG 1.03
- Revenue
- AGEN $160,427,000.00
- QSG $532,696,414.00
- Revenue This Year
- AGEN N/A
- QSG N/A
- Revenue Next Year
- AGEN $36.13
- QSG N/A
- P/E Ratio
- AGEN N/A
- QSG $1.89
- Revenue Growth
- AGEN 59.00
- QSG 13.53
- 52 Week Low
- AGEN $2.50
- QSG $1.41
- 52 Week High
- AGEN $19.69
- QSG $6.22
- Technical
- Relative Strength Index (RSI)
- AGEN 39.40
- QSG 30.90
- Support Level
- AGEN $2.65
- QSG $1.87
- Resistance Level
- AGEN $3.85
- QSG $3.13
- Average True Range (ATR)
- AGEN 0.29
- QSG 0.22
- MACD
- AGEN -0.02
- QSG -0.10
- Stochastic Oscillator
- AGEN 15.00
- QSG 5.56
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About QSG QuantaSing Group Limited
QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.